News and Press

FDNA and Centogene Announce First Grant of Molecular Testing Under the Face2Gene Unknown Forum Grant Program at the American Society of Human Genetics (ASHG) Annual Meeting

October 17, 2016

Collaboration between FDNA, the developer of the Face2Gene Suite and CENTOGENE, worldwide leader in genetic diagnostics, enabled the first grant of molecular testing for a patient with an unknown genetic disorder. The collaboration extends beyond financial support and includes the successful integration of Face2Gene LABS API with CENTOGENE’s bioinformatics pipeline to improve variant prioritization and […]

InHelix integrates with Face2Gene to improve CNV analysis

July 14, 2016

LEUVEN, Belgium — July 14, 2016 — Diploid today announces an update of InHelix, its software for CNV analysis in rare disease diagnostics. InHelix now integrates with Face2Gene, a software platform that facilitates detection of facial dysmorphic features from facial photos. The integration between the two apps allows clinicians to directly access and use dysmorphic […]

FDNA Announces New Grant for Genetic Testing of Patients with Unknown Diagnosis

March 14, 2016

Grant available exclusively for cases uploaded through the Face2Gene Online Unknown Forum FDNA Inc. (Boston, MA) announced a new grant program for patients with an unknown diagnosis. Under this grant, FDNA will sponsor for genetic testing to be performed for patients with cases uploaded through the Face2Gene Online Unknown Forum. The announcement was made at […]

FDNA to Launch Third Cycle of GIVE A FACE TO A SYNDROME at the ACMG Annual Meeting

March 7, 2016

Call for Research Proposals Issued at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting 2016 FDNA Inc. (Boston, MA) issued today a call to geneticists to submit research proposals to the third cycle of the GIVE A FACE TO A SYNDROME research program. The announcement coincides with the American College of Medical […]

FDNA invites geneticists and institutions to join 2nd cycle of “GIVE A FACE TO A SYNDROME”

October 5, 2015

Call for Research Proposals issued at the American Association of Human Genetics annual meeting ASHG2015 Boston, MA (PRweb) October 5th, 2015 – FDNA, a pioneer in computer-aided dysmorphology analysis, invites geneticists from around the world to join the second cycle of the “GIVE A FACE TO A SYNDROME” research program. The date of the release […]

FDNA to Launch Face2Gene Team Edition at ESHG 2015, Save Time, Collaborate and Share Knowledge when Evaluating Rare Disease Patients

May 28, 2015

Designed for teams and genetics departments, Face2Gene streamlines case and workflow management NEW YORK, May 28, 2015 /PRNewswire/ –FDNA® the pioneer in computer-aided dysmorphology analysis will launch Face2Gene Team Edition at the European Society of Human Genetics conference in Glasgow, Scotland on June 6-9, 2015. This newest addition to the Face2Gene family, powered by FDNA […]

The Face2Gene User Community

  • Using Face2Gene to reference all my department’s cases, share information with my colleagues and quickly look up relevant information in the London Medical Databases Online saves me hours of work every week and allows me to focus on my patients.

    Dr. Ibrahim Akalin

    Assoc. Prof. Ibrahim Akalin, MD, Medical Genetecist from the Istanbul Medeniyet University, Istanbul, Turkey

  • FDNA’s game-changing technology introduces an objective computer-aided dimension to the “art of dysmorphology”, transforming the analysis into an evidence-based science.

    Dr. Michael R. Hayden

    Chairman of FDNA’s Scientific Advisory Board & Steering Committee and Editor in Chief of Clinical Genetics

  • FDNA is developing technology that has the potential to help so many physicians and families by bringing them closer to a diagnosis- there are literally millions of individuals with unusual features around the world that lack a diagnosis and therefore lack information on natural history, recurrence risk and prevention of known complications.

    Dr. Judith G. Hall

    Professor Emerita of Pediatrics & Medical Genetics UBC & Children's and Women's Health Centre of BC

  • FDNA has been “right on the money”, providing me with relevant, accurate and insightful information for differential diagnoses.

    Dr. Cynthia J.R. Curry

    Professor of Pediatrics UCSF, Adjunct Professor of Pediatrics Stanford

  • I am excited to be a part of the FDNA community, promoting broad information sharing with my peers to amplify the scientific and clinical value of our community’s accumulated knowledge for the purpose of efficiently diagnosing individuals with rare genetic disorders.

    Dr. Karen W. Gripp

    Chief, Division of Medical Genetics A.I. duPont Hospital for Children

  • FDNA's idea of incorporating several dysmorphology resources (OMIM, GeneReviews), supported by their visual analytic technology, will be able to improve researching of genetic syndromes - all within a single mobile app.

    Dr. Chad Haldeman-Englert

    Assistant Professor Pediatrics at Wake Forest Baptist Medical Center

  • Given the advancement of visual analytical technology, it’s about time Dysmorphology is supported with computational capabilities and moving this to mobile support, is simply the next logical step.

    Dr. Chanika Phornphutkul

    Associate Professor of Pediatrics Director, Division of Human Genetics Department of Pediatrics Warren Alpert Medical School of Brown University

  • Having an archive of cases easily accessible from my mobile device anytime and anywhere is a long-time unmet need.

    Dr. Lynne Bird

    Rady Children's Specialists of San Diego

  • FDNA's solution is a huge leap forward for dysmorphology. It saves me significant time when I’m evaluating patients in my clinic and provides me with insightful tools that help me generate a differential diagnosis.

    Dr. David A. Chitayat

    Head of the Prenatal Diagnosis and Medical Genetics Program at Mount Sinai Hospital, Toronto

  • Shortly after learning about Face2Gene, I’ve started to incorporate this amazing tool into my workflow. Soon enough, Face2Gene’s analysis flushed out references that I would not have considered for several of my patients, which turned out to be their correct diagnosis

    Dr. Zvi U. Borochowitz

    Chairman (Retired) of The Simon Winter Institute for Human Genetics at Bnai-Zion Medical Center, Technion-Rappaport Faculty of Medicine

  • The Unknown Forum from Face2Gene is a great community platform for exchanging opinions regarding undiagnosed cases. It is straightforward to use and safe for exchange of medical data, thanks to the efforts of its developers and to the involvement of geneticists worldwide.

    Dr. Oana Moldovan

    Clinical Geneticist at the Hospital Santa Maria, CHLN, Lisbon, Portugal